Author Correction: Mechanisms and clinical activity of an EGFR and HER2 exon 20-selective kinase inhibitor in non-small cell lung cancer.
Robichaux JP, Elamin YY, Tan Z, Carter BW, Zhang S, Liu S, Li S, Chen T, Poteete A, Estrada-Bernal A, Le AT, Truini A, Nilsson MB, Sun H, Roarty E, Goldberg SB, Brahmer JR, Altan M, Lu C, Papadimitrakopoulou V, Politi K, Doebele RC, Wong KK, Heymach JV.
Robichaux JP, et al. Among authors: doebele rc.
Nat Med. 2024 Sep;30(9):2694-2695. doi: 10.1038/s41591-024-03178-1.
Nat Med. 2024.
PMID: 39164519
No abstract available.